Lv41
448 积分 2021-03-23 加入
Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial
1小时前
已完结
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial
1小时前
已完结
AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas
1个月前
已完结
Advancing Src kinase inhibition: From structural design to therapeutic innovation - A comprehensive review
3个月前
已完结
3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
4个月前
已完结
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
4个月前
已完结
Dimer‐specific regulatory mechanisms within the NF‐κB family of transcription factors
5个月前
已完结
Autoantibodies to Poly(ADP-Ribose) Polymerase in Centenarians: A Reappraisal of Grabar’s Hypothesis
6个月前
已完结
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
6个月前
已完结
Structure and Function of Poly(ADP-ribose) Polymerase-1: Role in Oxidative Stress-Related Pathologies
6个月前
已完结
皖公网安备34019202002308
